Ouro Medicines

South San Francisco, CA · Founded 2024 · Privately Held (backing)

Developer of innovative therapeutics designed to treat immune-mediated diseases by targeting underlying immune system dysfunction. Ouro Medicines is based in South San Francisco, CA and was founded in 2024. Its last reported valuation was $1.7 billion in Mar 2026. It has raised $120 million.

Last reported valuation
$1.7B
Oct 2026
Priced at
—
Total raised
$120.0M
Last round
—

Who backs Ouro Medicines?

9 investors
InvestorType
New Enterprise AssociatesVenture capital
NorwestVenture capital
Boyu CapitalVenture capital
UPMC EnterprisesVenture capital
Boai Wanwu (Shanghai) Venture Capital Management—
GSK—
LongRiver Investments—
Monograph Capital—
TPG—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ouro Medicines investors

9 investors are on record for Ouro Medicines, including New Enterprise Associates, Norwest, Boyu Capital and UPMC Enterprises.

Free account
More of Ouro Medicines with a free account
  • ·Watch Ouro Medicines: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Ouro Medicines. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View